Discover 1 curated intelligence briefings related to this specific topic.
The pharmaceutical industry is witnessing a fundamental reorganization as generative AI and quantum-inspired physics move drug discovery from random screening to intentional design, targeting rare genetic diseases and synthetic enzymes that outperform nature.
